| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:49 UTC |
|---|
| Update Date | 2023-02-21 17:18:09 UTC |
|---|
| HMDB ID | HMDB0014375 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Pregabalin |
|---|
| Description | Pregabalin is an anticonvulsant drug used for neuropathic pain, as an adjunct therapy for partial seizures, and in generalized anxiety disorder. It was designed as a more potent successor to gabapentin. Pregabalin is marketed by Pfizer under the trade name Lyrica. It is considered to have a dependence liability if misused, and is classified as a Schedule V drug in the U.S. [Wikipedia ] |
|---|
| Structure | InChI=1S/C8H17NO2/c1-6(2)3-7(5-9)4-8(10)11/h6-7H,3-5,9H2,1-2H3,(H,10,11)/t7-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (S)-3-Isobutyl gaba | ChEBI | | 3-Isobutyl gaba | ChEBI | | Lyrica | ChEBI | | 3-(Aminomethyl)-5-methylhexanoic acid | HMDB | | (S+)-3-isobutyl gaba | HMDB | | 3 Isobutyl gaba | HMDB | | (R-)-3-Isobutyl gaba | HMDB | | (S)-3-(Aminomethyl)-5-methylhexanoic acid | HMDB | | GABA, 3-isobutyl | HMDB |
|
|---|
| Chemical Formula | C8H17NO2 |
|---|
| Average Molecular Weight | 159.2261 |
|---|
| Monoisotopic Molecular Weight | 159.125928793 |
|---|
| IUPAC Name | (3S)-3-(aminomethyl)-5-methylhexanoic acid |
|---|
| Traditional Name | pregabalin |
|---|
| CAS Registry Number | 148553-50-8 |
|---|
| SMILES | CC(C)C[C@H](CN)CC(O)=O |
|---|
| InChI Identifier | InChI=1S/C8H17NO2/c1-6(2)3-7(5-9)4-8(10)11/h6-7H,3-5,9H2,1-2H3,(H,10,11)/t7-/m0/s1 |
|---|
| InChI Key | AYXYPKUFHZROOJ-ZETCQYMHSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as gamma amino acids and derivatives. These are amino acids having a (-NH2) group attached to the gamma carbon atom. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Amino acids, peptides, and analogues |
|---|
| Direct Parent | Gamma amino acids and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Gamma amino acid or derivatives
- Medium-chain fatty acid
- Amino fatty acid
- Branched fatty acid
- Fatty acyl
- Fatty acid
- Amino acid
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Amine
- Primary amine
- Organooxygen compound
- Organonitrogen compound
- Hydrocarbon derivative
- Primary aliphatic amine
- Organic oxide
- Organopnictogen compound
- Carbonyl group
- Organic oxygen compound
- Organic nitrogen compound
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 11.3 g/L | Not Available | | LogP | 1.3 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 2.11 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.8474 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 5.5 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 234.2 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 782.5 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 269.9 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 99.3 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 162.3 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 70.3 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 300.0 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 298.7 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 412.1 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 666.6 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 246.0 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 859.2 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 180.1 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 236.4 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 462.2 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 377.7 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 208.1 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Pregabalin,1TMS,isomer #1 | CC(C)C[C@H](CN)CC(=O)O[Si](C)(C)C | 1393.5 | Semi standard non polar | 33892256 | | Pregabalin,1TMS,isomer #2 | CC(C)C[C@H](CN[Si](C)(C)C)CC(=O)O | 1484.6 | Semi standard non polar | 33892256 | | Pregabalin,2TMS,isomer #1 | CC(C)C[C@H](CN[Si](C)(C)C)CC(=O)O[Si](C)(C)C | 1519.6 | Semi standard non polar | 33892256 | | Pregabalin,2TMS,isomer #1 | CC(C)C[C@H](CN[Si](C)(C)C)CC(=O)O[Si](C)(C)C | 1585.3 | Standard non polar | 33892256 | | Pregabalin,2TMS,isomer #1 | CC(C)C[C@H](CN[Si](C)(C)C)CC(=O)O[Si](C)(C)C | 1633.0 | Standard polar | 33892256 | | Pregabalin,2TMS,isomer #2 | CC(C)C[C@@H](CC(=O)O)CN([Si](C)(C)C)[Si](C)(C)C | 1674.2 | Semi standard non polar | 33892256 | | Pregabalin,2TMS,isomer #2 | CC(C)C[C@@H](CC(=O)O)CN([Si](C)(C)C)[Si](C)(C)C | 1621.2 | Standard non polar | 33892256 | | Pregabalin,2TMS,isomer #2 | CC(C)C[C@@H](CC(=O)O)CN([Si](C)(C)C)[Si](C)(C)C | 1772.4 | Standard polar | 33892256 | | Pregabalin,3TMS,isomer #1 | CC(C)C[C@@H](CC(=O)O[Si](C)(C)C)CN([Si](C)(C)C)[Si](C)(C)C | 1718.4 | Semi standard non polar | 33892256 | | Pregabalin,3TMS,isomer #1 | CC(C)C[C@@H](CC(=O)O[Si](C)(C)C)CN([Si](C)(C)C)[Si](C)(C)C | 1726.3 | Standard non polar | 33892256 | | Pregabalin,3TMS,isomer #1 | CC(C)C[C@@H](CC(=O)O[Si](C)(C)C)CN([Si](C)(C)C)[Si](C)(C)C | 1618.0 | Standard polar | 33892256 | | Pregabalin,1TBDMS,isomer #1 | CC(C)C[C@H](CN)CC(=O)O[Si](C)(C)C(C)(C)C | 1624.7 | Semi standard non polar | 33892256 | | Pregabalin,1TBDMS,isomer #2 | CC(C)C[C@H](CN[Si](C)(C)C(C)(C)C)CC(=O)O | 1699.0 | Semi standard non polar | 33892256 | | Pregabalin,2TBDMS,isomer #1 | CC(C)C[C@H](CN[Si](C)(C)C(C)(C)C)CC(=O)O[Si](C)(C)C(C)(C)C | 1974.2 | Semi standard non polar | 33892256 | | Pregabalin,2TBDMS,isomer #1 | CC(C)C[C@H](CN[Si](C)(C)C(C)(C)C)CC(=O)O[Si](C)(C)C(C)(C)C | 1956.5 | Standard non polar | 33892256 | | Pregabalin,2TBDMS,isomer #1 | CC(C)C[C@H](CN[Si](C)(C)C(C)(C)C)CC(=O)O[Si](C)(C)C(C)(C)C | 1911.0 | Standard polar | 33892256 | | Pregabalin,2TBDMS,isomer #2 | CC(C)C[C@@H](CC(=O)O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2068.3 | Semi standard non polar | 33892256 | | Pregabalin,2TBDMS,isomer #2 | CC(C)C[C@@H](CC(=O)O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 1987.2 | Standard non polar | 33892256 | | Pregabalin,2TBDMS,isomer #2 | CC(C)C[C@@H](CC(=O)O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 1978.1 | Standard polar | 33892256 | | Pregabalin,3TBDMS,isomer #1 | CC(C)C[C@@H](CC(=O)O[Si](C)(C)C(C)(C)C)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2376.6 | Semi standard non polar | 33892256 | | Pregabalin,3TBDMS,isomer #1 | CC(C)C[C@@H](CC(=O)O[Si](C)(C)C(C)(C)C)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2276.7 | Standard non polar | 33892256 | | Pregabalin,3TBDMS,isomer #1 | CC(C)C[C@@H](CC(=O)O[Si](C)(C)C(C)(C)C)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2012.7 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Pregabalin GC-MS (Non-derivatized) - 70eV, Positive | splash10-001i-9100000000-ff23b21ef03ce99e7cce | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Pregabalin GC-MS (1 TMS) - 70eV, Positive | splash10-001i-9100000000-99ad7be9a2ea5e94fae2 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Pregabalin GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Pregabalin LC-ESI-QFT , negative-QTOF | splash10-0a4i-0900000000-555454e7e8e11dab591d | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pregabalin LC-ESI-QFT , negative-QTOF | splash10-0a4i-0900000000-1a52554257d7f4b1c62e | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pregabalin LC-ESI-QFT , negative-QTOF | splash10-0a4i-0900000000-d48cd6eeef012787cc04 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pregabalin LC-ESI-QFT , negative-QTOF | splash10-0a4i-0900000000-4b11df5208caa2e97dd2 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pregabalin LC-ESI-QFT , negative-QTOF | splash10-0a4i-0900000000-605dc241ffd3a07a9220 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pregabalin LC-ESI-QTOF , positive-QTOF | splash10-01ox-0900000000-fb081cde39dde2ce89f8 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pregabalin LC-ESI-QTOF , positive-QTOF | splash10-0006-0900000000-3d95bb5278c7866658a0 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pregabalin LC-ESI-QTOF , positive-QTOF | splash10-0006-0900000000-96cebf4a3610cbf02059 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pregabalin LC-ESI-QFT , positive-QTOF | splash10-0006-8900000000-385584fca9e88b90a95b | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pregabalin LC-ESI-QFT , positive-QTOF | splash10-0006-9800000000-a1c6718b087b06101b8d | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pregabalin LC-ESI-QFT , positive-QTOF | splash10-0a4i-9200000000-5f291c943a1d1ae214ad | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pregabalin LC-ESI-QFT , positive-QTOF | splash10-0a4i-9100000000-5283d02d98611a8c2c38 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pregabalin LC-ESI-QFT , positive-QTOF | splash10-0a4i-9000000000-8797f8d2776fcdb4b6d5 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pregabalin LC-ESI-QFT , positive-QTOF | splash10-0a4i-9000000000-a9ddfcf2032ffc9f53ad | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pregabalin 10V, Positive-QTOF | splash10-01ox-0900000000-f61d6c12dadd60399296 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pregabalin 75V, Positive-QTOF | splash10-0a4i-9000000000-37e1f57223b0ba6b95f6 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pregabalin 60V, Positive-QTOF | splash10-0a4i-9100000000-ea797f17647a8718608d | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pregabalin 30V, Positive-QTOF | splash10-0006-0900000000-96cebf4a3610cbf02059 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pregabalin 10V, Positive-QTOF | splash10-01ox-0900000000-142ab34d1881e6e3e247 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pregabalin 10V, Positive-QTOF | splash10-01ox-1900000000-0d022bd7f0e9af9f06f8 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pregabalin 20V, Positive-QTOF | splash10-03ed-9800000000-fe82df47c3ac7c9c39e3 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pregabalin 40V, Positive-QTOF | splash10-0a5a-9000000000-20b509ce412ff8d7fe8c | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pregabalin 10V, Negative-QTOF | splash10-0bt9-0900000000-d07b85e7e0d11beb1781 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pregabalin 20V, Negative-QTOF | splash10-0bt9-1900000000-6351cf9406ff25f78268 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pregabalin 40V, Negative-QTOF | splash10-0a4m-9300000000-8f1f021c89d9316d47a0 | 2016-08-03 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum |
IR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
|---|